Development of nanoparticles based on amphiphilic cyclodextrins for the delivery of active substances

Archive ouverte

Augis, Luc | Nerbø Reiten, Ingeborg | Førde, Jan-Lukas | Casas-Solvas, Juan | Sizun, Christina | Bizien, Thomas | Rajkovic, Ivan | Larquet, Eric | Michelet, Alexandre | Collot, Mayeul | Lesieur, Sylviane | Herfindal, Lars | Legrand, François-Xavier

Edité par CCSD ; Elsevier -

International audience. Although amphiphilic cyclodextrin derivatives (ACDs) serve as valuable building blocks for nanomedicine formulations, their widespread production still encounters various challenges, limiting large-scale manufacturing. This work focuses on a robust alternative pathway using mineral base catalysis to transesterify β-cyclodextrin with long-chain vinyl esters, yielding ACD with modular and controlled hydrocarbon chain grafting. ACDs with a wide range of degrees of substitution (DS) were reliably synthesized, as indicated by extensive physicochemical characterization, including MALDI-TOF mass spectrometry. The influence of various factors, including the type of catalyst and the length of the hydrocarbon moiety of the vinyl ester, was studied in detail. ACDs were assessed for their ability to form colloidal suspensions by nanoprecipitation, with or without PEGylated phospholipid. Small-angle X-ray scattering and cryo-electron microscopy revealed the formation of nanoparticles with distinct ultrastructures depending on the DS: an onion-like structure for low and very high DS, and reversed hexagonal organization for DS between 4.5 and 6.1. We confirmed the furtivity of the PEGylated versions of the nanoparticles through complement activation experiments and that they were well tolerated in-vivo on a zebrafish larvae model after intravenous injection. Furthermore, a biodistribution experiment showed that the nanoparticles left the bloodstream within 10 h after injection and were phagocytosed by macrophages.

Suggestions

Du même auteur

Repurposing chlorpromazine for anti-leukaemic therapy with the drug-in-cyclodextrin-in-liposome nanocarrier platform

Archive ouverte | Gundersen, Edvin Tang | CCSD

International audience. Acute myeloid leukaemia (AML) accounts for 30 % of adult leukaemia cases, predominantly affecting individuals over 60. The standard “7 + 3” intensive chemotherapy regimen is unsuitable for ma...

Development of a pediatric oral solution of ONC201 using nicotinamide to enhance solubility and stability

Archive ouverte | Annereau, Maxime | CCSD

International audience. Diffuse intrinsic pontine glioma (DIPG) poses a significant treatment challenge in pediatric patients due to its aggressive nature and difficulty in crossing the blood–brain barrier with effe...

Interaction of dequalinium chloride with phosphatidylcholine bilayers: A biophysical study with consequences on the development of lipid-based mitochondrial nanomedicines

Archive ouverte | Sauvage, Félix | CCSD

International audience. Dequalinium (DQ) has been proposed as a mitochondrial targeting ligand for nanomedicines, including liposomes, given the implication of these organelles in many diseases. This original study ...

Chargement des enrichissements...